Progression and metastasis of lung cancer

被引:0
作者
Helmut H. Popper
机构
[1] Medical University of Graz,Research Unit Molecular Lung and Pleura Pathology, Institute of Pathology
来源
Cancer and Metastasis Reviews | 2016年 / 35卷
关键词
Lung cancer; Angiogenesis; Metastasis; Hypoxia; Migration; Circulation; Epithelial-mesenchymal transition; Brain; Bone;
D O I
暂无
中图分类号
学科分类号
摘要
Metastasis in lung cancer is a multifaceted process. In this review, we will dissect the process in several isolated steps such as angiogenesis, hypoxia, circulation, and establishment of a metastatic focus. In reality, several of these processes overlap and occur even simultaneously, but such a presentation would be unreadable. Metastasis requires cell migration toward higher oxygen tension, which is based on changing the structure of the cell (epithelial-mesenchymal transition), orientation within the stroma and stroma interaction, and communication with the immune system to avoid attack. Once in the blood stream, cells have to survive trapping by the coagulation system, to survive shear stress in small blood vessels, and to find the right location for extravasation. Once outside in the metastatic locus, tumor cells have to learn the communication with the “foreign” stroma cells to establish vascular supply and again express molecules, which induce immune tolerance.
引用
收藏
页码:75 / 91
页数:16
相关论文
共 1035 条
[1]  
Gabor S(2004)Invasion of blood vessels as significant prognostic factor in radically resected T1-3N0M0 non-small-cell lung cancer European Journal of Cardio-Thoracic Surgery 25 439-442
[2]  
Renner H(2014)EGFR mutation and brain metastasis in pulmonary adenocarcinomas Journal of Thoracic Oncology 9 195-199
[3]  
Popper H(2015)Specific organ metastases and survival in metastatic non-small-cell lung cancer Molecular and Clinical Oncology 3 217-221
[4]  
Anegg U(2014)EGFR mutated non-small cell lung cancer patients: more prone to development of bone and brain metastases? Lung Cancer 84 86-91
[5]  
Sankin O(2011)SOX2 gene amplification and protein overexpression are associated with better outcome in squamous cell lung cancer Modern Pathology 24 944-953
[6]  
Matzi V(1999)Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival Journal of Pathology 188 369-377
[7]  
Lindenmann J(2000)Heregulin selectively upregulates vascular endothelial growth factor secretion in cancer cells and stimulates angiogenesis Oncogene 19 3460-3469
[8]  
Smolle Juttner FM(2002)A DNA vaccine against VEGF receptor 2 prevents effective angiogenesis and inhibits tumor growth Nature Medicine 8 1369-1375
[9]  
Shin DY(2004)Angiogenesis and extracellular matrix remodelling in bronchioloalveolar carcinomas: distinctive patterns in mucinous and non-mucinous tumours Histopathology 44 251-256
[10]  
Na II(2005)Overexpression of vascular endothelial growth factor and its receptors in bronchial dypslasia demonstrated by quantitative RT-PCR analysis Lung Cancer 48 31-45